期刊文献+

弥漫性大B细胞淋巴瘤侵犯骨髓的病理学观察 被引量:7

Pathologic observation of diffuse large B cell lymphoma bone marrow involvement
原文传递
导出
摘要 目的探讨弥漫性大B细胞淋巴瘤(DLBCL)侵犯骨髓的病理学特点、诊断与鉴别诊断。方法对24例DLBCL侵犯骨髓的骨髓活检HE染色切片进行形态学观察,20例免疫组化(IHC)法进行免疫表型分析。将其中10例髓外部位原发的NHL患者的骨髓与髓外部位瘤细胞的形态学进行对比观察。结果DLBCL侵犯骨髓的方式依次为:弥漫型14例,间质型6例,混合型2例,结节型1例,窦内型1例。侵犯程度为重度15例,中度4例,轻度5例。瘤细胞形态学类型为中心母细胞型21例,免疫母细胞型3例。瘤细胞表达CD20、CD45RN、Pax5等一种或多种B细胞的标记。不表达CD3、CD4580、CD5、CD10、TdT、CyclinD1、CD38、CD68、MPO。10例髓外原发淋巴瘤患者的骨髓与其髓外部位瘤细胞形态一致。结论DLBCL侵犯骨髓多具有特殊的骨髓病理学特点。少数轻度、间质型浸润以及混有较多小淋巴细胞者,免疫组化有助于鉴别诊断。骨髓活检对于DLBCL侵犯骨髓的诊断具有重要意义。 Objective To explore the bone marrow pathology ,diagnosis and differential diagnosis of diffuse large B cell lymphoma (DLBCL) bone marrow involvement(BMI). Methods Morphologie observation was peffornled on bone marrow biopsies (BMB) stained with Hematoxylin-eosin(HE) from 24 patients with DLBCL BMI. Immunohistoehemistry (IHC) for immunophenotyping was conducted on 20 patients. The morphology of lymphoma cells in the medullary and extramedu]lary was compared for 10 cases with primary lymphoma. Results Patterns of DLBCL BMI were presented by: diffuse(14 cases), interstitial(6 cases), mixed (2 case), nodular (1 ease) and intrasinusoidal (1 case) types. The extent of BMI included severe(15 cases), moderate(4 cases) and mild (5 cases). The common morphological variants was eentroblastie (21 cases) and the remainder was immunoblastie (3 cases). IHC showed the lymphoma cells expressing one or more B cell markers, including CD~ CD45~ and Pax5. They were negative for CD3, CD45Rts CDs, CDl0, TdT, Cyclin D1, CD3s, CD6s and MPO.The morphology of lymphoma cells in the medullary was concordant with extramedullary of 10 cases with primary lymphoma. Conclusion For most patients, bone marrow pathology of DLBCL BMI is distinctive. In the minority, IHC is contributive to the differentiation of the mild and interstitial pattern of BMI and merged with more small lymphocytes. Bone marrow biopsy is significantly important in the diagnosis of DLBCL BMI.
出处 《白血病.淋巴瘤》 CAS 2010年第2期78-81,共4页 Journal of Leukemia & Lymphoma
关键词 淋巴瘤 大细胞 弥漫型 骨髓侵犯 骨髓活检 病理形态 免疫组织化学 Lympboma, large-cell, diffuse Bone marrow involvement Bone marrow biopsy Pathomorphology Immunohistochemistry
  • 相关文献

参考文献11

二级参考文献70

  • 1刘恩彬,陈辉树,邱录贵.淋巴瘤侵犯骨髓的病理与临床研究进展[J].诊断病理学杂志,2004,11(3):196-198. 被引量:21
  • 2陈辉树.淋巴瘤侵犯骨髓的诊断与鉴别诊断[J].白血病.淋巴瘤,2004,13(5):308-312. 被引量:16
  • 3陈辉树,刘恩彬,李占琦,杨晴英,方立环,徐茂强,罗彦英,康永录,曹鹏飞.46例脾脏淋巴组织肿瘤病理形态免疫表型及分子遗传学探讨[J].中国肿瘤临床,2005,32(12):700-705. 被引量:10
  • 4Campbell J, Seymour JF, Matthews J,et al. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement. Eur J Haematol, 2006, 76 : 473- 480.
  • 5Yan Y, Chan WC, Weisenburger DD,et al. Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma. J Clin Oncol, 1995,13:1336-1342.
  • 6Talaulikar D, Dahlstrom JE, Shadboh B,et al. Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: resuits of a pilot study. Pathology,2007,39:580-585.
  • 7Chung R, Lai R, Wei P, et al. Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index. Blood ,2007,110 : 1278-1282.
  • 8Shipp MA, Aquino SL, Hart'is NL. A predictive model for aggressive non-Hodgkin' s lymphoma. The International Non-Hodgkin' s Lymphoma Prognostic-Factors Project. N Engl J Med, 1993,329 : 987 -993.
  • 9Sehn LH, Berry B, Chhanabhai M,et al. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood ,2007,109 : 1857-1861.
  • 10Cheson BD, Homing SJ, Coiffier B,et al. Report of an international workshop to standardize response criteria for non-Hodgkin' s lymphomas. NCI Sponsored International Working Group. J Chn Oncol, 1999,17 : 1244-1253.

共引文献60

同被引文献46

  • 1管永靖,陈克敏.磁共振成像在诊断淋巴瘤骨髓浸润中的临床应用[J].上海第二医科大学学报,2005,25(3):282-285. 被引量:2
  • 2张伶,王仁法.MR增强扫描定量检测恶性淋巴瘤骨髓浸润的诊断价值[J].放射学实践,2005,20(6):516-516. 被引量:1
  • 3Steiner RM,Mitchell DG,Rao VM,et al.Magnetic resonance imaging of diffuse bone marrow disease.Radiol Clin North Am,1999,31:383-409.
  • 4Frisch B,Lewis SM,Barkhangt R,et al.Biopsy pathology of bone and bone marrow.London:Chapman and Hall,1985:180-188.
  • 5Viswanatha D, Foucar K. Hodgkin and non-Hodgkin lymphoma involving bone marrow.Semin Diagn Pathol,2003,20:196-210.
  • 6Altehoefer C, Blum U, Bathmann J, et al. Comparative diagnostic accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma.J Clin Oncol,1997,15:1754-1760.
  • 7Hoane BR,Shields AF,Porter BA,et al.Detection of lymphomatous bone marrow involvement with magnetic resonance imaging. Blood,1991,78:728-738.
  • 8Vinnicombe SJ,Reznek RH.Computerised tomography in the staging of Hodgkin's disease and non-Hodgkins lymphoma. Eur J Nucl Med Mol Imaging,2003,30:s42-55.
  • 9Takagi S, Tsunoda S, Tanaka O. Bone marrow involvement in lymphoma: the importance of marrow magnetic resonance imaging.Leuk Lymphoma,1998,29:515-522.
  • 10Smith SR,Williams CE,Davies JM,et al.Bone marrow disorders:characterization with quantitative MR imaging.Radiology,1989,172:805-810.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部